Erivedge

vismodegib · Genentech

Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Erivedge, covering 2012-01-30 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) [Phase 2]